菜单
2026/01/07 / 2023
The company was selected into the "2022 China Small Molecule Drug Enterprise Innovation Power TOP30 Ranking"
The company was selected into the "2022 China Small Molecule Drug Enterprise Innovation Power TOP30 Ranking"
2026-01-07

The company was selected into the "2022 China Small Molecule Drug Enterprise Innovation Power TOP30 Ranking"


Next
Aitribond® (Ainuomiti/ACC008 Tablets) was included in the National Medical Insurance Catalog, and Ainuovirine/ACC007 Tablets successfully renewed its contract679